OR-GUROBI-OPTIMIZATION
16.11.2021 15:03:14 CET | Business Wire | Press release
Gurobi Optimization, LLC , creator of the world’s fastest mathematical optimization solver, today announced the release of Gurobi Optimizer 9.5. This release provides customers with an even faster compute engine, with impressive performance improvements across all supported problem types.
Gurobi 9.5 also includes new features that make it well suited for enterprise use, including:
- Seamless Docker Deployments: Run Gurobi in container environments, easily, with the Gurobi Web License Service (WLS).
- User-Level Management: Manage users and assign permission levels in a centralized location, by integrating Gurobi Compute Server and Cluster Manager with LDAP repositories.
- Better API Key Management: Label API keys with descriptive information in the Cluster Manager to simplify API key tracking and management.
Customers will discover over a dozen enhancements across the product, such as native support for Apple M1, powerful new heuristics for non-convex quadratic models, norm constraints, deterministic work measures, memory limit parameters, and more user control of IIS computation, as well as improvements to callbacks and tuning.
“I’m confident that our customers will be really pleased with Gurobi 9.5. And happy customers are the foundation upon which our whole business is built,” said Dr. Edward Rothberg, Chief Executive Officer and Co-founder of Gurobi Optimization.
Gurobi 9.5 also showcases the company’s continued support for Python—the most popular programming language in the world—with an improved Python interface and support for Python 3.10.
“One of the most challenging parts of running a modern business is managing complexity. Every decision you make affects other decisions. With Gurobi Optimizer, you can explore all the possibilities and all the implications—and identify your best course of action, in seconds,” added Dr. Rothberg.
“Even though the Gurobi Optimizer is the fastest mathematical optimizer in the world, we’re not going to rest on our laurels. We will keep pushing to improve and innovate because we’re passionate about mathematical optimization and the difference it makes in solving real-world problems,” said Dr. Tobias Achterberg, Vice President of Research and Development (R&D) at Gurobi Optimization.
The team’s commitment to continual improvement is evident in the performance numbers. Gurobi Optimizer 9.5 has boosted its speeds across the board, including:
- Primal Simplex: 23% faster overall, 43% faster on hard models
- Dual Simplex: 20% faster overall, 43% faster on hard models
- Barrier : 18% faster overall, 56% faster on hard models
- Concurrent LP: 14% faster overall, 54% faster on hard models
- MIP : 15% faster overall, 27% faster on hard models
- Convex MIQP : 30% faster overall, 68% faster on hard models
- Convex MIQCP : 33% faster overall, 78% faster on hard models
- Non-Convex MIQCP : 3.0x faster overall, 7.5x faster on hard models
“Our customers rely on us for solving extremely complex challenges. Our technology makes that possible. But our secret sauce is our team of specialists and PhDs, as well as our partner network. These are the people who make Gurobi come to life—working closely with our customers and helping them succeed,” added Dr. Achterberg.
To learn more about Gurobi 9.5, please visit https://www.gurobi.com/9.5 .
About Gurobi Optimization
Gurobi produces the world’s fastest and most powerful mathematical optimization solver – the Gurobi Optimizer – which is used by leading global companies across more than 40 different industries to rapidly solve their complex, real-world problems and make automated decisions that optimize their efficiency and profitability. As the market leader in mathematical optimization software, we aim to deliver not only the best solver, but also the best support – so that companies can fully leverage the power of mathematical optimization (on its own or in combination with other AI techniques such as machine learning) to drive optimal business decisions and outcomes.
Founded in 2008, Gurobi has operations across the USA, Europe, and Asia and has more than 2,500 customers globally including SAP, Air France, Uber, and the National Football League (NFL). For more information, please visit https://www.gurobi.com/ or call +1 713 871 9341.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005125/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Comsysto Reply Supports Audi in Evolving Its B2B Used Car Platform With an AI-Based Multi-Agent System24.7.2026 10:00:00 CEST | Press release
Comsysto Reply, the Reply Group company specialised in agile software development and cloud-native solutions, has partnered with Audi on the ongoing development of its “Used Car Platform”, the company’s central digital marketplace for B2B used car trading. A tailored multi-agent solution accelerates software development, reduces repetitive activities, and enables faster delivery of new features. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260724143396/en/ Comsysto Reply, the Reply Group company specialised in agile software development and cloud-native solutions, has partnered with Audi in evolving its digital marketplace for B2B used car trading with an AI-based multi-agent system The platform represents a key digital sales channel for Audi’s used car sector. Since 2025, it has accounted for nearly 100% of the car manufacturer's B2B business. Building on this operational relevance, Audi and Comsysto Reply have introduced
Samsung Epis Holdings Reports Second Quarter and Half-Year 2026 Financial Results24.7.2026 09:20:00 CEST | Press release
Samsung Bioepis reports revenue of 847.1 billion KRW and an operating profit of 230.6 billion KRW in the first half of 2026, recording 6% year-over-year growthExpanding direct commercialization in Europe to five products with the launch of OPUVIZ™ 40 mg/mL vial, a biosimilar to Eylea1 (aflibercept)First to announce preliminary results from Phase 1, 3 clinical studies for SB27, a biosimilar candidate referencing Keytruda2 (pembrolizumab)Samsung Epis Holdings continuing to secure next-generation growth engines through establishment of a global R&D hub in China Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced its financial results for the second quarter and first half of fiscal year 2026. “We delivered solid first-half 2026 results, achieving 6% growth year-over-year. This performance demonstrates the resilience of our biosimilar portfolio in the global market," said Kyung-Ah Kim, President and Chi
Ant International’s Alipay+ Adds New Bank Partners Amid Cross-border Mobile Payment Boom in Asia Pacific24.7.2026 06:10:00 CEST | Press release
Through Alipay+, banks are able to quickly build new revenue streams, increase digital engagement and introduce new value-added services for users through cross-border payments Alipay+, Ant International's unified wallet gateway, is adding more bank partners to its network of over 50 leading digital wallets and financial institutions. Its global bank partners range from incumbent banks to fully digital banks. The latest banking partner to join Alipay+ is Hang Seng Bank, Alipay+’s first banking partner in Hong Kong. Hang Seng Mobile App users can now make payments via QR code scan in the Chinese Mainland and overseas by simply using the Hang Seng Mobile App at over 100 million merchants across more than 55 countries/regions. Accelerating revenue growth through cross-border mobile payments Demand for outbound cross-border payments from Asia Pacific is projected to increase faster than the global average. Alongside growing adoption of digital wallets, consumer-to-consumer (C2C) and consum
mimik Operationalizes Agentic AI on the AMD Ryzen™ AI Embedded X100 Series23.7.2026 20:30:00 CEST | Press release
mimik today announced mimOE™ Embedded Edition, a package of its Agentix Operating Engine and a set of purpose-built tools for the AMD Ryzen™ AI Embedded X100 Series processor, the newest processor in a family designed for physical AI, autonomous systems, and industrial automation. Available to download today, mimOE Embedded Edition gives OEMs, tier-1 suppliers, system integrators, and agent developers the path to operationalize Agentix-Native systems (aka Agentic AI), in which autonomous agents can reason, coordinate, and act directly on devices, from PoC to scaled operations with certainty. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260723555565/en/ Agentic AI operations are both CPU and GPU bound. Enterprises can now scale with certainty. Generative AI has centered on the GPU. Agentix-Native systems must spread the work. In a real multi-agent workflow traced by mimik, more than 80 percent of operations were CPU work: d
U.S. Federal Court Permanently Bans 19 Online Sellers of Fake Urolithin A Supplements and Awards $5.3 Million in Damages to Timeline23.7.2026 16:27:00 CEST | Press release
Default judgment follows Timeline’s independent laboratory testing showing products sold under 19 online brands contained no detectable Urolithin A, or far less than advertised Timeline (Amazentis SA), the Swiss life-sciences company that pioneered the postbiotic ingredient Urolithin A and its branded form Mitopure®, together with its U.S. subsidiary Timeline Longevity, Inc., announced today that the U.S. District Court for the District of Massachusetts has granted the companies’ motion for default judgments and permanent injunctions against 19 online sellers found to have marketed and sold nutritional supplements falsely advertised as containing Urolithin A. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722951066/en/ Timeline longevity supplement powered by Mitopure; proprietary, highly pure Urolithin A. The order, entered July 15, 2026 by Judge Myong J. Joun in Amazentis SA et al. v. The Partnerships and Unincorporated
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
